Literature DB >> 28482779

Evaluating the impact of treating the optimal subgroup.

Alexander R Luedtke1, Mark J van der Laan2.   

Abstract

Suppose we have a binary treatment used to influence an outcome. Given data from an observational or controlled study, we wish to determine whether or not there exists some subset of observed covariates in which the treatment is more effective than the standard practice of no treatment. Furthermore, we wish to quantify the improvement in population mean outcome that will be seen if this subgroup receives treatment and the rest of the population remains untreated. We show that this problem is surprisingly challenging given how often it is an (at least implicit) study objective. Blindly applying standard techniques fails to yield any apparent asymptotic results, while using existing techniques to confront the non-regularity does not necessarily help at distributions where there is no treatment effect. Here, we describe an approach to estimate the impact of treating the subgroup which benefits from treatment that is valid in a nonparametric model and is able to deal with the case where there is no treatment effect. The approach is a slight modification of an approach that recently appeared in the individualized medicine literature.

Entities:  

Keywords:  Individualized treatment; non-regular inference; stabilized one-step estimator; subgroup analyses

Mesh:

Year:  2017        PMID: 28482779      PMCID: PMC7244101          DOI: 10.1177/0962280217708664

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  14 in total

Review 1.  General guidance on exploratory and confirmatory subgroup analysis in late-stage clinical trials.

Authors:  Alex Dmitrienko; Christoph Muysers; Arno Fritsch; Ilya Lipkovich
Journal:  J Biopharm Stat       Date:  2016       Impact factor: 1.051

2.  Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation.

Authors:  Peter M Rothwell
Journal:  Lancet       Date:  2005 Jan 8-14       Impact factor: 79.321

3.  The challenge of subgroup analyses--reporting without distorting.

Authors:  Stephen W Lagakos
Journal:  N Engl J Med       Date:  2006-04-20       Impact factor: 91.245

4.  On the distinction between interaction and effect modification.

Authors:  Tyler J VanderWeele
Journal:  Epidemiology       Date:  2009-11       Impact factor: 4.822

5.  Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification.

Authors:  David M Kent; Rodney A Hayward
Journal:  JAMA       Date:  2007-09-12       Impact factor: 56.272

6.  Subgroup identification based on differential effect search--a recursive partitioning method for establishing response to treatment in patient subpopulations.

Authors:  Ilya Lipkovich; Alex Dmitrienko; Jonathan Denne; Gregory Enas
Journal:  Stat Med       Date:  2011-07-22       Impact factor: 2.373

7.  Subgroup analysis and other (mis)uses of baseline data in clinical trials.

Authors:  S F Assmann; S J Pocock; L E Enos; L E Kasten
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321

8.  Inference about the expected performance of a data-driven dynamic treatment regime.

Authors:  Bibhas Chakraborty; Eric B Laber; Ying-Qi Zhao
Journal:  Clin Trials       Date:  2014-06-12       Impact factor: 2.486

9.  Targeted Learning of the Mean Outcome under an Optimal Dynamic Treatment Rule.

Authors:  Mark J van der Laan; Alexander R Luedtke
Journal:  J Causal Inference       Date:  2015-03

10.  STATISTICAL INFERENCE FOR THE MEAN OUTCOME UNDER A POSSIBLY NON-UNIQUE OPTIMAL TREATMENT STRATEGY.

Authors:  Alexander R Luedtke; Mark J van der Laan
Journal:  Ann Stat       Date:  2016-03-17       Impact factor: 4.028

View more
  9 in total

1.  Internet interventions for mental health in university students: A systematic review and meta-analysis.

Authors:  Mathias Harrer; Sophia H Adam; Harald Baumeister; Pim Cuijpers; Eirini Karyotaki; Randy P Auerbach; Ronald C Kessler; Ronny Bruffaerts; Matthias Berking; David D Ebert
Journal:  Int J Methods Psychiatr Res       Date:  2018-12-26       Impact factor: 4.035

2.  Study protocol for pragmatic trials of Internet-delivered guided and unguided cognitive behavior therapy for treating depression and anxiety in university students of two Latin American countries: the Yo Puedo Sentirme Bien study.

Authors:  Corina Benjet; Ronald C Kessler; Alan E Kazdin; Pim Cuijpers; Yesica Albor; Nayib Carrasco Tapias; Carlos C Contreras-Ibáñez; Ma Socorro Durán González; Sarah M Gildea; Noé González; José Benjamín Guerrero López; Alex Luedtke; Maria Elena Medina-Mora; Jorge Palacios; Derek Richards; Alicia Salamanca-Sanabria; Nancy A Sampson
Journal:  Trials       Date:  2022-06-02       Impact factor: 2.728

3.  Invited Commentary: New Directions in Machine Learning Analyses of Administrative Data to Prevent Suicide-Related Behaviors.

Authors:  Robert M Bossarte; Chris J Kennedy; Alex Luedtke; Matthew K Nock; Jordan W Smoller; Cara Stokes; Ronald C Kessler
Journal:  Am J Epidemiol       Date:  2021-12-01       Impact factor: 4.897

4.  Using Administrative Data to Predict Suicide After Psychiatric Hospitalization in the Veterans Health Administration System.

Authors:  Ronald C Kessler; Mark S Bauer; Todd M Bishop; Olga V Demler; Steven K Dobscha; Sarah M Gildea; Joseph L Goulet; Elizabeth Karras; Julie Kreyenbuhl; Sara J Landes; Howard Liu; Alex R Luedtke; Patrick Mair; William H B McAuliffe; Matthew Nock; Maria Petukhova; Wilfred R Pigeon; Nancy A Sampson; Jordan W Smoller; Lauren M Weinstock; Robert M Bossarte
Journal:  Front Psychiatry       Date:  2020-05-06       Impact factor: 4.157

5.  Propensity score weighting for causal subgroup analysis.

Authors:  Siyun Yang; Elizabeth Lorenzi; Georgia Papadogeorgou; Daniel M Wojdyla; Fan Li; Laine E Thomas
Journal:  Stat Med       Date:  2021-05-12       Impact factor: 2.497

6.  Evaluating the heterogeneous effect of a modifiable risk factor on suicide: The case of vitamin D deficiency.

Authors:  Jose R Zubizarreta; John C Umhau; Patricia A Deuster; Lisa A Brenner; Andrew J King; Maria V Petukhova; Nancy A Sampson; Boris Tizenberg; Sanjaya K Upadhyaya; Jill A RachBeisel; Elizabeth A Streeten; Ronald C Kessler; Teodor T Postolache
Journal:  Int J Methods Psychiatr Res       Date:  2021-11-05       Impact factor: 4.035

7.  A Machine-Learning Approach for Estimating Subgroup- and Individual-Level Treatment Effects: An Illustration Using the 65 Trial.

Authors:  Zia Sadique; Richard Grieve; Karla Diaz-Ordaz; Paul Mouncey; Francois Lamontagne; Stephen O'Neill
Journal:  Med Decis Making       Date:  2022-05-24       Impact factor: 2.749

8.  Development and Validation of a Machine Learning Individualized Treatment Rule in First-Episode Schizophrenia.

Authors:  Chi-Shin Wu; Alex R Luedtke; Ekaterina Sadikova; Hui-Ju Tsai; Shih-Cheng Liao; Chen-Chung Liu; Susan Shur-Fen Gau; Tyler J VanderWeele; Ronald C Kessler
Journal:  JAMA Netw Open       Date:  2020-02-05

Review 9.  Predictive approaches to heterogeneous treatment effects: a scoping review.

Authors:  Alexandros Rekkas; Jessica K Paulus; Gowri Raman; John B Wong; Ewout W Steyerberg; Peter R Rijnbeek; David M Kent; David van Klaveren
Journal:  BMC Med Res Methodol       Date:  2020-10-23       Impact factor: 4.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.